Notably, the rate of improvement of glycometabolic parameters in particular HbA1c, triglycerides, fasting glucose, insulin and HOMA was significantly steeper in patients with T2DM that in non-diabetic patients (Figures 1, 2). This evidence concerns the gene INS and type 2 diabetes mellitus.